444 filings
Page 7 of 23
SC 13G
04yo18sso n7dfp
3 May 22
Cellectis / Long Focus Capital Management ownership change
2:15pm
6-K
w2q1p vc4si7v637qsad
28 Apr 22
Cellectis Publishes Two Articles in Nature Communications Providing Strong Preclinical Validation of UCART123 to Treat AML and BPDCN
8:00am
6-K
jc7crte ojybo08d6je
27 Apr 22
Cellectis Receives $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
6:31am
6-K
vv8gsio7jwq kxkyvlku
8 Apr 22
Current report (foreign)
4:30pm
6-K
o9r2xmfdfg
11 Mar 22
Cellectis to Participate in Two Upcoming Investor Conferences in March
4:33pm
S-8 POS
fz501utjpjrm
3 Mar 22
Registration of securities for employees (post-effective amendment)
5:30pm
6-K
aoos 7nxz5f
3 Mar 22
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results
4:55pm
6-K
0n51haw31 hw2qimzvi
24 Feb 22
Current report (foreign)
4:42pm
6-K
ejb fl4aofn2ledi
18 Feb 22
Current report (foreign)
4:47pm
SC 13G/A
yvchl 6stlt
11 Feb 22
Cellectis / Capital International Investors ownership change
11:19am
6-K
fn2477t
10 Feb 22
Cellectis Appoints Bing Wang, PhD, MBA
4:35pm
SC 13G/A
u4na36uqak
9 Feb 22
Cellectis / ARK Investment Management ownership change
3:15pm
SC 13G
g7m ud0slig1ilgbrbr
12 Jan 22
Cellectis / BAILLIE GIFFORD & CO ownership change
6:13am
6-K
hoppzhsmt1uj239
10 Jan 22
Announces Removal of FDA Clinical Hold on their Clinical Trials
4:36pm
6-K
kfxvk594nhn t5s
4 Jan 22
Current report (foreign)
4:38pm
6-K
gu874jit4aadmt5sox
13 Dec 21
Current report (foreign)
9:02am
6-K
3vwsjtg3bvd3yhp n9
7 Dec 21
Current report (foreign)
4:08pm
6-K
4yprdc 1k9etzr66niil
24 Nov 21
Current report (foreign)
4:06pm
6-K
nwbvz
18 Nov 21
Cytovia and Cellectis Expand Their TALENĀ® Gene-Edited iNK Partnership to Enable Broader Collaboration in China
4:30pm